Bell Investment Advisors, Inc Seagen Inc. Transaction History

Bell Investment Advisors, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$191.51 - $216.16 $1,340 - $1,513	-7 Reduced 12.5%	49 $10,000
Q2 2023 Aug 09, 2023	SELL	$187.64 - $206.25 $375 - $412	-2 Reduced 3.45%	56 $10,000
Q1 2023 May 10, 2023	BUY	$127.59 - $203.08 $1,531 - $2,436	12 Added 26.09%	58 $11,000
Q4 2022 Feb 08, 2023	BUY	$117.37 - $139.17 $469 - $556	4 Added 9.52%	46 $5,000
Q3 2022 Nov 09, 2022	SELL	$135.27 - $180.11 $676 - $900	-5 Reduced 10.64%	42 $6,000

Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $3,373 - $5,559	31 Added 193.75%	47 $8,000
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $1,710 - $2,290	-12 Reduced 42.86%	16 $2,000
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $3,988 - $4,754	28 New	28 $5,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Bell Investment Advisors, Inc with notifications on news.